Homeostatic expansion of T cells during immune insufficiency generates autoimmunity

Cell

Volumn 117, Issue 2, 2004, Pages 265-277

  King, Cecile ^a   Ilic, Alex ^a   Koelsch, Kersten ^b   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 21;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CELL CYCLE; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; HOMEOSTASIS; IMMUNE DEFICIENCY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE;

ANIMALIA;

EID: 1942453326     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(04)00335-6     Document Type: Article

References (66)

1. Akbar A.N., Borthwick N.J., Wickremasinghe R.G., Panayoitidis P., Pilling D., Bofill M., Krajewski S., Reed J.C., Salmon M. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal. selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression Eur. J. Immunol. 26:1996;294-299.
2. Armitage R.J., Beckmann M.P., Idzerda R.L., Alpert A., Fanslow W.C. Regulation of interleukin 4 receptors on human T cells. Int. Immunol. 2:1990;1039-1045.
3. Asao H., Okuyama C., Kumaki S., Ishii N., Tsuchiya S., Foster D., Sugamura K. Cutting edge. the common gamma-chain is an indispensable subunit of the IL-21 receptor complex J. Immunol. 167:2001;1-5.
4. Bateman H.E., Kirou K.A., Paget S.A., Crow M.K., Yee A.M. Remission of juvenile rheumatoid arthritis after infection with parvovirus B19. J. Rheumatol. 26:1999;2482-2484.
5. Bennett F., Luxenberg D., Ling V., Wang I.M., Marquette K., Lowe D., Khan N., Veldman G., Jacobs K.A., Valge-Archer V.E.et al. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation. attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses J. Immunol. 170:2003;711-718.
6. Berzins S.P., Venanzi E.S., Benoist C., Mathis D. T-cell compartments of prediabetic NOD mice. Diabetes. 52:2003;327-334.
7. Dardenne M., Lepault F., Bendelac A., Bach J.F. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur. J. Immunol. 19:1989;889-895.
8. Denny P., Lord C.J., Hill N.J., Goy J.V., Levy E.R., Podolin P.L., Peterson L.B., Wicker L.S., Todd J.A., Lyons P.A. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes. 46:1997;695-700.
9. Di Sabatino A., D'Alo S., Millimaggi D., Ciccocioppo R., Parroni R., Sciarra G., Cifone M.G., Corazza G.R. Apoptosis and peripheral blood lymphocyte depletion in coeliac disease. Immunology. 103:2001;435-440.
10. Ernst B., Lee D.S., Chang J.M., Sprent J., Surh C.D. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity. 11:1999;173-181.
11. Fowell D., McKnight A.J., Powrie F., Dyke R., Mason D. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123:1991;37-64.
12. Gleeson P.A., Toh B.H., van Driel I.R. Organ-specific autoimmunity induced by lymphopenia. Immunol. Rev. 149:1996;97-125.
13. Grayson J.M., Zajac A.J., Altman J.D., Ahmed R. Cutting edge. increased expression of Bcl-2 in antigen-specific memory CD8+ T cells J. Immunol. 164:2000;3950-3954.
14. Green E.A., Choi Y., Flavell R.A. Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells. highly potent regulators of diabetes that require TRANCE-RANK signals Immunity. 16:2002;183-191.
15. Greenhill J.P. Ignaz Semmelweis, Oliver Wendell Holmes and puerperal infection. Int. Surg. 45:1966;28-31.
16. Hernan M.A., Zhang S.M., Lipworth L., Olek M.J., Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology. 12:2001;301-306.
17. Holt P.G. Programming for responsiveness to environmental antigens that trigger allergic respiratory disease in adulthood is initiated during the perinatal period. Environ. Health Perspect. 106:1998;795-800.
18. Issacs J.D., Greer S., Sharma S., Symmons D., Smith M., Johnston J., Waldmann H., Hale G., Hazleman B.L. Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum. 44:2001;1998-2008.
19. Kaaba S.A., Al-Harbi S.A. Abnormal lymphocyte subsets in Kuwaiti patients with type-1 insulin-dependent diabetes mellitus and their first-degree relatives. Immunol. Lett. 47:1995;209-213.
20. Kataoka S., Satoh J., Fujiya H., Toyota T., Suzuki R., Itoh K., Kumagai K. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes. 32:1983;247-253.
21. Kedl R.M., Rees W.A., Hildeman D.A., Schaefer B., Mitchell T., Kappler J., Marrack P. T cells compete for access to antigen-bearing antigen-presenting cells. J. Exp. Med. 192:2000;1105-1113.
22. King C., Mueller Hoenger R., Malo Cleary M., Murali-Krishna K., Ahmed R., King E., Sarvetnick N. Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses. Nat. Med. 7:2001;206-214.
23. Kishimoto H., Sprent J. A defect in central tolerance in NOD mice. Nat. Immunol. 2:2001;1025-1031.
24. Kouskoff V., Korganow A.S., Duchatelle V., Degott C., Benoist C., Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell. 87:1996;811-822.
25. Kukreja A., Maclaren N.K. Autoimmunity and diabetes. J. Clin. Endocrinol. Metab. 84:1999;4371-4378.
26. Kwoh C.K. Epidemiology of the rheumatic diseases. Curr. Opin. Rheumatol. 4:1992;138-144.
27. La Gruta N.L., Driel I.R., Gleeson P.A. Peripheral T cell expansion in lymphopenic mice results in a restricted T cell repertoire. Eur. J. Immunol. 30:2000;3380-3386.
28. Leonard W.J., Shores E.W., Love P.E. Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol. Rev. 148:1995;97-114.
29. Marrack P., Mitchell T., Bender J., Hildeman D., Kedl R., Teague K., Kappler J. T-cell survival. Immunol. Rev. 165:1998;279-285.
30. Mehta D.S., Wurster A.L., Whitters M.J., Young D.A., Collins M., Grusby M.J. IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170:2003;4111-4118.
31. Mendelsohn J.A. Like all that lives'. biology, medicine and bacteria in the age of Pasteur and Koch Hist. Philos. Life Sci. 24:2002;3-36.
32. Morgan D.J., Liblau R., Scott B., Fleck S., McDevitt H.O., Sarvetnick N., Lo D., Sherman L.A. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157:1996;978-983.
33. O'Reilly L.A., Huang D.C., Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:1996;6979-6990.
34. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., Gross J.A., Johnston J., Madden K., Xu W., West J.et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 408:2000;57-63.
35. Parrish-Novak J., Foster D.C., Holly R.D., Clegg C.H. Interleukin-21 and the IL-21 receptor. novel effectors of NK and T cell responses J. Leukoc. Biol. 72:2002;856-863.
36. Peacock C.D., Kim S.K., Welsh R.M. Attrition of virus-specific memory CD8+ T cells during reconstitution of lymphopenic environments. J. Immunol. 171:2003;655-663.
37. Permar S.R., Moss W.J., Ryon J.J., Douek D.C., Monze M., Griffin D.E. Increased thymic output during acute measles virus infection. J. Virol. 77:2003;7872-7879.
38. Powrie F., Leach M.W., Mauze S., Caddle L.B., Coffman R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5:1993;1461-1471.
39. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes. 43:1994;613-621.
40. Rietz C., Screpanti V., Brenden N., Bohme J., Fernandez C. Overexpression of bcl-2 in T cells affects insulitis in the nonobese diabetic mouse. Scand. J. Immunol. 57:2003;342-349.
41. Rocha B., Freitas A.A., Coutinho A.A. Population dynamics of T lymphocytes. Renewal rate and expansion in the peripheral lymphoid organs. J. Immunol. 131:1983;2158-2164.
42. Sadelain M.W., Qin H.Y., Lauzon J., Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes. 39:1990;583-589.
43. Sai P., Senecat O., Martignat L., Gouin E. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice. Clin. Exp. Immunol. 97:1994;138-145.
44. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A., Bluestone J.A. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:2000;431-440.
45. Salomon B., Rhee L., Bour-Jordan H., Hsin H., Montag A., Soliven B., Arcella J., Girvin A.M., Padilla J., Miller S.D., Bluestone J.A. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J. Exp. Med. 194:2001;677-684.
46. Sarvetnick N., Shizuru J., Liggitt D., Martin L., McIntyre B., Gregory A., Parslow T., Stewart T. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature. 346:1990;844-847.
47. Satoh J., Shintani S., Nobunaga T., Sugawara S., Makino S., Toyota T., Goto Y. NOD mice with high incidence of type 1 diabetes are not T lymphocytopenic. Tohoku J. Exp. Med. 155:1988;151-158.
48. Schaller J.G. Immunodeficiency and autoimmunity. Birth Defects Orig. Artic. Ser. 11:1975;173-184.
49. Serreze D.V., Johnson E.A., Chapman H.D., Graser R.T., Marron M.P., DiLorenzo T.P., Silveira P., Yoshimura Y., Nathenson S.G., Joyce S. Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool. Diabetes. 50:2001;1992-2000.
50. Silva M., Benito A., Sanz C., Prosper F., Ekhterae D., Nunez G., Fernandez-Luna J.L. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. J. Biol. Chem. 274:1999;22165-22169.
51. Sitnicka E., Ruscetti F.W., Priestley G.V., Wolf N.S., Bartelmez S.H. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 88:1996;82-88.
52. Sleasman J.W. The association between immunodeficiency and the development of autoimmune disease. Adv. Dent. Res. 10:1996;57-61.
53. Snow J.W., Abraham N., Ma M.C., Bronson S.K., Goldsmith M.A. Transgenic bcl-2 is not sufficient to rescue all hematolymphoid defects in STAT5A/5B-deficient mice. Exp. Hematol. 31:2003;1253-1258.
54. Sprent J., Surh C.D. Cytokines and T cell homeostasis. Immunol. Lett. 85:2003;145-149.
55. Surh C.D., Sprent J. Homeostatic T cell proliferation. how far can T cells be activated to self-ligands? J. Exp. Med. 192:2000;F9-F14.
56. Szanya V., Ermann J., Taylor C., Holness C., Fathman C.G. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2002;2461-2465.
57. Tanchot C., Rosado M.M., Agenes F., Freitas A.A., Rocha B. Lymphocyte homeostasis. Semin. Immunol. 9:1997;331-337.
58. Theofilopoulos A.N., Dummer W., Kono D.H. T cell homeostasis and systemic autoimmunity. J. Clin. Invest. 108:2001;335-340.
59. Todd J.A., Wicker L.S. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity. 15:2001;387-395.
60. Tough D.F., Sprent J. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1994;1127-1135.
61. Twarog F.J., Rose N.R. Transfer of autoimmune thyroiditis of the rat with lymph node cells. J. Immunol. 104:1970;1467-1475.
62. Verdaguer J., Schmidt D., Amrani A., Anderson B., Averill N., Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1997;1663-1676.
63. Wicker L.S., Appel M.C., Dotta F., Pressey A., Miller B.J., DeLarato N.H., Fischer P.A., Boltz R.C. Jr., Peterson L.B. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J. Exp. Med. 176:1992;67-77.
64. Wicker L.S., Todd J.A., Prins J.B., Podolin P.L., Renjilian R.J., Peterson L.B. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J. Exp. Med. 180:1994;1705-1713.
65. Zhang X., Fujii H., Kishimoto H., LeRoy E., Surh C.D., Sprent J. Aging leads to disturbed homeostasis of memory phenotype CD8(+) cells. J. Exp. Med. 195:2002;283-293.
66. Zhang J.L., Foster D., Sebald W. Human IL-21 and IL-4 bind to partially overlapping epitopes of common gamma-chain. Biochem. Biophys. Res. Commun. 300:2003;291-296.